tiprankstipranks
Cellectar Biosciences Inc (CLRB)
:CLRB
US Market

Cellectar Biosciences (CLRB) Stock Investors

Compare
1,319 Followers
Based on 786,921 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLRB
On average, investors allocate 0.00% of their portfolios to CLRB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 786,921 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLRB

>0.1%
Last 7
Days
2.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLRB, out of 786,921 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLRB Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.00%
$1.53
Based on the activity of investors who made their portfolios public
The table shows changes in CLRB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLRB Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.01%
-0.58%
-0.79%
1.69B
Industrials
DraftKings
5.18%
+0.51%
-1.25%
47.11B
Consumer Cyclical
Viking Therapeutics
3.81%
-1.39%
+2.47%
3.40B
Healthcare
Nio
9.05%
-0.24%
-0.92%
9.27B
Consumer Cyclical
Block
3.90%
+0.66%
-0.22%
52.06B
Technology
Lucid Group
5.55%
+0.05%
+0.17%
9.97B
Consumer Cyclical
Carnival
5.70%
-0.49%
-0.46%
33.98B
Consumer Cyclical
Marathon Digital Holdings
5.15%
-0.89%
-2.14%
5.74B
Financial
Riot Platforms
4.88%
-1.06%
+0.74%
4.22B
Financial
JD
4.78%
+0.87%
+3.01%
64.20B
Consumer Cyclical
Based on the activity of 786,921 active portfolios
Open your Smart Portfolio

CLRB Investor Analysis

CLRB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.8%
of CLRB holders
are under 35
Average Segment Performance
Average P/E Ratio39.08
Beta11.18
Dividend Yield3.84%
CLRB investors between 35–55

Between 35–55

3.5%
Last 30 days
Holdings Change
58.4%
of CLRB holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.72
Beta20.89
Dividend Yield3.28%
CLRB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.7%
of CLRB holders
are over 55
Average Segment Performance
Average P/E Ratio36.08
Beta10.18
Dividend Yield3.48%
Overview of age group and performance of CLRB stock investors
See who invests in CLRB according to age group and performance.

FAQ

How many retail Investors hold CLRB?
<0.1% of TipRanks' retail investors hold CLRB in their portfolios.
    What is CLRB Investor Sentiment?
    CLRB’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of CLRB in the last 7 days?
      >0.1% of TipRanks' retail investors changed their holding of CLRB in the last 7 days.
        What percentage of retail investors changed their holding of CLRB in the last 30 days?
        ▲ 2.3% of TipRanks' retail investors changed their holding of CLRB in the last 30 days.
          What is the average age of retail investors who hold CLRB?
          The average age of CLRB Holders is between 35–55.
            What other stocks have CLRB investors also bought?
            CLRB Investors also bought PLUG, DKNG, VKTX, NIO, XYZ, LCID, CCL, MARA, RIOT, JD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              AZNAstraZeneca
              BDXBecton Dickinson
              BSXBoston Scientific
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis